Nyxoah (NYXH) Competitors $10.83 -0.08 (-0.73%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NYXH vs. FNA, EYE, AXGN, CBLL, BVS, AVNS, IRMD, BFLY, SIBN, and KIDSShould you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include Paragon 28 (FNA), National Vision (EYE), AxoGen (AXGN), CeriBell (CBLL), Bioventus (BVS), Avanos Medical (AVNS), Iradimed (IRMD), Butterfly Network (BFLY), SI-BONE (SIBN), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. Nyxoah vs. Paragon 28 National Vision AxoGen CeriBell Bioventus Avanos Medical Iradimed Butterfly Network SI-BONE OrthoPediatrics Paragon 28 (NYSE:FNA) and Nyxoah (NASDAQ:NYXH) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability. Do institutionals and insiders believe in FNA or NYXH? 63.6% of Paragon 28 shares are owned by institutional investors. 15.3% of Paragon 28 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is FNA or NYXH more profitable? Paragon 28 has a net margin of -25.31% compared to Nyxoah's net margin of -1,043.93%. Paragon 28's return on equity of -37.90% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Paragon 28-25.31% -37.90% -18.22% Nyxoah -1,043.93%-51.68%-40.11% Does the media prefer FNA or NYXH? In the previous week, Paragon 28 had 6 more articles in the media than Nyxoah. MarketBeat recorded 8 mentions for Paragon 28 and 2 mentions for Nyxoah. Paragon 28's average media sentiment score of 0.94 beat Nyxoah's score of 0.00 indicating that Paragon 28 is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Paragon 28 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nyxoah 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in FNA or NYXH? Nyxoah received 3 more outperform votes than Paragon 28 when rated by MarketBeat users. However, 83.33% of users gave Paragon 28 an outperform vote while only 71.70% of users gave Nyxoah an outperform vote. CompanyUnderperformOutperformParagon 28Outperform Votes3583.33% Underperform Votes716.67%NyxoahOutperform Votes3871.70% Underperform Votes1528.30% Which has more risk and volatility, FNA or NYXH? Paragon 28 has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.35, meaning that its share price is 35% more volatile than the S&P 500. Do analysts recommend FNA or NYXH? Paragon 28 currently has a consensus target price of $15.60, indicating a potential upside of 39.06%. Nyxoah has a consensus target price of $17.00, indicating a potential upside of 56.52%. Given Nyxoah's higher probable upside, analysts clearly believe Nyxoah is more favorable than Paragon 28.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Paragon 28 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Nyxoah 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, FNA or NYXH? Nyxoah has lower revenue, but higher earnings than Paragon 28. Paragon 28 is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioParagon 28$216.39M4.34-$57.53M-$0.74-15.16Nyxoah$4.70MN/A-$46.77M-$1.87-5.81 SummaryParagon 28 beats Nyxoah on 13 of the 18 factors compared between the two stocks. Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NYXH vs. The Competition Export to ExcelMetricNyxoahSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$4.83B$5.39B$9.14BDividend YieldN/A52.58%5.37%4.00%P/E Ratio-5.8026.0988.2717.52Price / SalesN/A61.251,286.0780.21Price / CashN/A50.8936.6032.90Price / BookN/A7.904.954.68Net Income-$46.77M$13.87M$117.96M$224.57M7 Day Performance16.53%4.37%2.54%3.26%1 Month Performance35.59%11.45%3.49%5.30%1 Year Performance141.09%33.41%27.05%22.74% Nyxoah Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NYXHNyxoah2.7951 of 5 stars$10.83-0.7%$17.00+57.0%+142.2%$0.00$4.70M-5.79110News CoveragePositive NewsFNAParagon 283.2297 of 5 stars$10.70+3.4%$15.60+45.8%-3.8%$895.80M$245.00M-14.46343,000Gap UpEYENational Vision2.7049 of 5 stars$10.58+0.6%$13.50+27.6%-44.2%$833.18M$2.18B-52.9014,000Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageAXGNAxoGen1.5151 of 5 stars$18.25+1.1%$15.00-17.8%+106.0%$803.15M$180.86M-57.03450Positive NewsCBLLCeriBellN/A$20.84-0.4%$32.60+56.4%N/A$746.57M$60.04M0.00N/ABVSBioventus3.3721 of 5 stars$9.16-1.3%$15.00+63.8%+109.2%$743.38M$555.06M-15.021,200AVNSAvanos Medical4.072 of 5 stars$15.84+4.2%N/A-15.6%$727.96M$681.50M46.593,771Short Interest ↓IRMDIradimed4.6047 of 5 stars$56.51-0.1%$60.00+6.2%+33.4%$716.15M$71.31M38.71110BFLYButterfly Network1.0295 of 5 stars$3.35-6.7%$3.00-10.4%+246.3%$713.76M$76.22M-7.28460Gap UpSIBNSI-BONE4.2672 of 5 stars$16.23+18.3%$23.00+41.7%-10.0%$680.65M$157.04M-17.64350High Trading VolumeKIDSOrthoPediatrics4.1575 of 5 stars$25.00+2.3%$39.00+56.0%-5.8%$605.40M$189.67M-20.33200Short Interest ↑ Related Companies and Tools Related Companies Paragon 28 Competitors National Vision Competitors AxoGen Competitors CeriBell Competitors Bioventus Competitors Avanos Medical Competitors Iradimed Competitors Butterfly Network Competitors SI-BONE Competitors OrthoPediatrics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NYXH) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.